Rocket


News + Filings
Transactions



Calvin Sandra

DateNameSymbolTypeSecuritySharesPriceValueOwnershipReported
01/25/2023Travere Therapeutics, Inc.RTRXSaleCommon Stock192$21.63$4.2k 01/24/2023
01/24/2023Travere Therapeutics, Inc.RTRXSaleCommon Stock905$21.90$19.8k 01/24/2023
09/13/2022Travere Therapeutics, Inc.RTRXSaleCommon Stock349$28.00$9.8k 09/13/2022
05/11/2022Travere Therapeutics, Inc.RTRXSaleCommon Stock445$21.92$9.8k 05/10/2022
05/10/2022Travere Therapeutics, Inc.RTRXSaleCommon Stock436$21.51$9.4k 05/10/2022
01/31/2022Travere Therapeutics, Inc.RTRXGrantCommon Stock8.8k$0.00$0 01/31/2022
01/31/2022Travere Therapeutics, Inc.RTRXSaleCommon Stock798$26.51$21.2k 01/31/2022
01/31/2022Travere Therapeutics, Inc.RTRXGrantEmployee stock option (right to buy)17.5k$27.50$481.2k 01/31/2022
01/24/2022Travere Therapeutics, Inc.RTRXSaleCommon Stock934$24.58$23k 01/24/2022

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy